Vicriviroc maleate 是一种可口服，可透过血脑屏障的CCR5选择性拮抗剂，同时抑制外周血单核细胞中的 HIV-1 的活性。

Vicriviroc maleate(Sch-417690) is a piperazine-based CCR5 receptor antagonist with activity against human immunodeficiency virus. The IC50 value is 0.91 nM in clinical development for the treatment of HIV-1.

599179-03-0

C32H42F3N5O6

649.712

SCH-D (maleate);SCH-417690 (maleate);维立韦罗马来酸盐

H2O:25 mg/mL (38.48 mM),Need ultrasonic and warming
DMSO:50 mg/mL (76.96 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years